Position in CERS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,767,866
+$8,693,727 QoQ
Shares Held
3,002,694
+7271.1% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 186 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $483,618,661 across 20 Medical Devices names. CERS ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
478,029 | $150,502,650 | |
| 2 | ABT |
Abbott Laboratories
|
1,551,489 | $140,782,111 | |
| 3 | MDT |
Medtronic plc
|
1,210,929 | $94,730,975 | |
| 4 | EW |
Edwards Lifesciences Corp
|
264,757 | $23,949,918 | |
| 5 | DXCM |
Dexcom Inc
|
197,082 | $13,273,472 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
146,414 | $12,604,781 | |
| 7 | CERS |
Cerus Corp
This page
|
3,002,694 | $8,767,866 | |
| 8 | BSX |
Boston Scientific Corp
|
190,089 | $8,112,998 |
All Filings in CERS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,767,866 | 3,002,694 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $74,139 | 40,736 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $107,319 | 52,097 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $82,834 | 52,097 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $73,456 | 52,097 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $72,414 | 52,097 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $17,495 | 11,361 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $19,768 | 11,361 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $19,995 | 11,361 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,472 | 11,361 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $24,539 | 11,361 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $18,404 | 11,361 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $27,948 | 11,361 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $33,742 | 11,361 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $41,467 | 11,361 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $281,664 | 78,240 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $415,920 | 78,624 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $419,216 | 76,360 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $582,125 | 85,481 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $524,909 | 86,192 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $484,998 | 82,064 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $410,110 | 68,238 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $460,027 | 66,478 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $781,360 | 124,818 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $559,792 | 84,817 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $358,970 | 77,198 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||